About Cyplasin Biomedical
Founded in 2007 and headquartered in Edmonton, Canada with a research laboratory close to Berlin, Germany, CBL is dedicated to bringing new anticancer therapeutics to the marketplace. The Company's current goal is to develop and commercialize the anticancer properties of Cyplasin-SC(TM) against skin cancer and melanoma.
Facts about Cyplasin Biomedical
Facts about Cyplasin Biomedical
- Focus : Manufacturer
- Industry : Pharma